Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas (clinicaltrials.gov) - Sep 30, 2026 - P1 | N=23 | Completed | Sponsor: Alaunos Therapeutics | Unknown status ➔ Completed
Trial completion • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Solid Tumor
|